Express Pharma - January 2025

I denne utgaven

India's Foremost Pharma & Biotech Magazine ~ Outlook 2025

Will Epygen's biosimilars bets pay off?

Debayan Ghosh, founder, Epygen Group, has ambitious plans to snag a slice of the booming $70 billion global biosimilar pie. In a conversation with Viveka Roychowdhury, he analyses the journey so far, spanning pandemic preparedness projects like protein-based vaccines, building up pipeline revenue streams in diabetes, oncology, immunology and cardiovascular biosimilars, and his strategies to scale up and expand to other therapeutics like anti-obesity drugs

9 mins

Innovation, partnerships and best practices: Priorities for biopharma in 2025

Industry experts highlight the progress made by the Indian biopharma sector, and suggest pathways to promote growth

3 mins

Sustaining excellence: The evolving role of quality in pharma

In the ever-evolving landscape of the pharma industry, the pursuit of quality remains a cornerstone of success. As stringent regulatory frameworks, rising patient expectations, and the increasing pace of innovation, transforms the pharma industry, the definition of quality is also evolving. From ensuring compliance with global standards to embracing cutting-edge technologies like Al-driven quality control, the industry is navigating a paradigm shift in how it approaches product integrity, safety, and efficacy. In this New Year issue, pharma experts explore how crucial it is to foster a culture of quality across organisations and deliver better healthcare outcomes

5 mins

Nutraceuticals 2025: Mapping growth, innovation, and consumer-centric trends

Industry experts highlight the evolving dynamics, regulatory needs, and personalised solutions driving the nutra market ahead of 2025

4 mins

Growth mantras for 2025: Innovation, Partnerships, Sustainability

Innovation, synergy, and sustainability are shaping the trajectory of India's pharma sector, unlocking new frontiers of growth, inform industry stakeholders

2 mins

Trends 2025: Redefining the pharma supply chain

Saurabh Gupta, Global Head of Supply Chain, Lupin highlights trends such as Al integration, digitalisation and sustainability that are shaping a future-ready supply chain

4 mins

KPMG 2024 Life Sciences CEO Outlook

This recent KPMG report explores the perspectives and priorities of life sciences CEOs amid economic and geopolitical uncertainty, focusing on growth strategies, digital transformation, ESG goals, and workforce challenges. Excerpts from the report

7 mins

We aim to strengthen our presence in Asian and MENA regions, with particular emphasis on India

Matthias Poslovski, Chief Sales Officer, Optima Pharma, speaks on the company's evolution and shares insights on emerging trends like personalised medicine, digitalisation, and Al-driven technologies, while outlining his company's strategies for market expansion, particularly in Asia and MENA, with a focus on the Indian pharma sector, in an exclusive interaction with Lakshmipriya Nair

4 mins

CILICANT is changing the way we think about active packaging

Team CILICANT shared insights into their journey of innovation, customer-centric solutions, and their ambitious plans for global expansion. In this engaging dialogue, the team also shed light on their unique value proposition, recent achievements, and strategies for adapting to a rapidly evolving pharma landscape, in an exclusive conversation with Express Pharma

4 mins

Revolutionising pharma the adaptive way

Adaptive manufacturing offers better performance, efficient management of diverse products, a reduced machine footprint, faster batch changes, and enhanced operational sustainability

3 mins

Les alle historiene fra Express Pharma

Express Pharma Magazine Description:

Express Pharma formerly Express Pharma Pulse, one of the most widely read publication in pharmaceutical media since 1994, published by one of the oldest and most respected media group in India, the Indian Express Group. Express Pharma is India’s foremost Pharma & Biotech publication, published in a handy size and an international format, designed for readers convenience. Organized into four sections – Market, Management, Research and Pharma Life, it caters to the information needs of all levels of the pharmaceutical and biotech professionals. EP offers the widest geographic reach, focused business segment coverage and the sure means to reach the senior management and decision makers across the Industry.